Back to Search
ERIN RAYBURN, DMD
DMD
General Practice Dentistry
NPI: 1669852588Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
4140-20(MS)
Research & Publications (20)
FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer.
PMID 19274441·Invest New Drugs·2010
7-preclinical
Synthesis and in vitro anti-lung cancer activity of novel 1, 3, 4, 8-tetrahydropyrrolo [4, 3, 2-de]quinolin-8(1H)-one alkaloid analogs.
PMID 19442212·Med Chem·2009
7-preclinical
In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues.
PMID 19451594·Clin Cancer Res·2009
7-preclinical
Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action.
PMID 19203832·Cancer Lett·2009
7-preclinical
Anti-lung cancer effects of novel ginsenoside 25-OCH(3)-PPD.
PMID 19131140·Lung Cancer·2009
7-preclinical
Recent advances in validating MDM2 as a cancer target.
PMID 19538162·Anticancer Agents Med Chem·2009
6-review
Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible?
PMID 18549978·Drug Discov Today·2008
6-review
Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides.
PMID 18324646·Prostate·2008
4-observational
20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action.
PMID 18253123·Br J Cancer·2008
7-preclinical
Experimental therapy for colon cancer: anti-cancer effects of TLR9 agonism, combination with other therapeutic modalities, and dependence upon p53.
PMID 17487373·Int J Oncol·2007
7-preclinical
Extracellular activity of cyclic AMP-dependent protein kinase as a biomarker for human cancer detection: distribution characteristics in a normal population and cancer patients.
PMID 17416772·Cancer Epidemiol Biomarkers Prev·2007
8-other
Dexamethasone as a chemosensitizer for breast cancer chemotherapy: potentiation of the antitumor activity of adriamycin, modulation of cytokine expression, and pharmacokinetics.
PMID 17332934·Int J Oncol·2007
7-preclinical
In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng.
PMID 16924497·Cancer Chemother Pharmacol·2007
8-other
Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function.
PMID 17310983·Oncogene·2007
8-other
Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases.
PMID 17275947·Lung Cancer·2007
8-other
Isolation, structural determination, and evaluation of the biological activity of 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol [20(S)-25-OCH3-PPD], a novel natural product from Panax notoginseng.
PMID 17266624·Med Chem·2007
8-other
Immunomodulatory oligonucleotides as novel therapy for breast cancer: pharmacokinetics, in vitro and in vivo anticancer activity, and potentiation of antibody therapy.
PMID 16928832·Mol Cancer Ther·2006
7-preclinical
Experimental therapy of prostate cancer with an immunomodulatory oligonucleotide: effects on tumor growth, apoptosis, proliferation, and potentiation of chemotherapy.
PMID 16927305·Prostate·2006
7-preclinical
Chemotherapy and chemosensitization of non-small cell lung cancer with a novel immunomodulatory oligonucleotide targeting Toll-like receptor 9.
PMID 16818518·Mol Cancer Ther·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 68 KING RD
HATTIESBURG, MS 39402 - Phone
- (601) 951-9021
Quick Facts
- NPI
- 1669852588
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile